By Scientia Professor Louisa Jane Degenhardt

Journal articles

Topp LJ; Degenhardt LJ; Kaye SS; Darke S, 2003, 'The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system', Drug and Alcohol Review, 21, pp. 341 - 348

Degenhardt LJ; Darke S; Dillon PG, 2003, 'The prevalence and correlates of gamma-hydroxybutyrate GHB) overdose amon Australian users', Addiction, 98, pp. 199 - 204

Darke S; Mattick RP; Degenhardt LJ, 2003, 'The Ratio of Non-Fatal to Fatal Heroin Overdose', Addiction, 98, pp. 1169 - 1172

Hickman M; Taylor C; Chatterjee A; Degenhardt L; Frischer M; Hay G; Tilling K; Wiessing L; Griffiths P; McKetin R, 2002, 'Estimating the prevalence of problematic drug use: A review of methods and their application', Bulletin on Narcotics, 54, pp. 15 - 32

Teesson M; Dietrich U; Degenhardt L; Lynskey M; Beard J, 2002, 'Substance use disorders in an Australian community survey', Drug and Alcohol Review, 21, pp. 275 - 280, http://dx.doi.org/10.1080/0959523021000002741

Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B, 2002, 'CDT, GGT, and AST as markers of alcohol use: The WHO/ISBRA Collaborative Project', Alcoholism Clinical and Experimental Research, 26, pp. 332 - 339, http://dx.doi.org/10.1111/j.1530-0277.2002.tb02542.x

Degenhardt LJ; Hall WD, 2002, 'Cannabis and Psychosis', Current psychiatry reports, 4, pp. 191 - 196

Degenhardt LJ; Lynskey MT, 2002, 'Cannabis dependence in young adults: an Australian population study', Addiction, 97, pp. 187 - 194

Degenhardt LJ; Lynskey MT; Hall WD, 2002, 'Cannabis use and mental health in young people: cohort study', British Medical Journal: Clinical Research, 325, pp. 1195 - 1198

Degenhardt LJ; Lynskey MT, 2002, 'Diagnostic orphans among young adult cannabis users: persons who report dependence symptoms but do not meet diagnostic criteria', Drug and Alcohol Dependence, 67, pp. 205 - 212

Degenhardt LJ; Darke S; Dillon PG, 2002, 'GHB use amon Australians: characteristics, use patterns and assoicated harm', Drug and Alcohol Dependence, 67, pp. 89 - 94

Andrews JG; Corry JC; Issakidis CN; Slade TN, 2002, 'Selected major risk factors & global & refional burden of disease', Lancet, 360, pp. 1347 - 1360

Ezzati M; Rodgers A; Vander Hoorn S; Murray CJ; the Comparative Risk Assessment Collaborating Group , 2002, 'Selected major risk factors and global and regional burden of disease', Lancet, 360, pp. 1347 - 1360

Degenhardt LJ, 2002, 'Young people`s drug use; when heroin is less available', Youth Studies Australia, 3, pp. 11 - 16

Degenhardt L; Hall W; Lynskey M, 2001, 'Co-morbidity between alcohol, tobacco and cannabis use: Reply', ADDICTION, 96, pp. 1862 - 1863, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172551200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Degenhardt L; Hall W; Lynskey M, 2001, 'Co-morbidity between alcohol, tobacco and cannabis use: Reply to David Fergusson [8]', Addiction, 96, pp. 1862 - 1863

Hall WD; Degenhardt LJ; Currow D, 2001, 'Allowing the medical use of cannabis', Medical Journal of Australia, 175, pp. 39 - 40, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143512.x

Tabakoff B; Helander A; Conigrave KM; Martinez L; Hoffman PL; Whitfield J; Degenhardt L; Saunders J; Baron A; Glanz J, 2001, 'WHO/ISBRA study on state and trait markers in alcoholism', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 25, pp. 99S - 103S, http://dx.doi.org/10.1097/00000374-200105051-00018

Degenhardt LJ; Hall WD; Lynskey MT, 2001, 'Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis', Addiction, pp. 1603 - 1614

Degenhardt LJ; Hall WD; Adelstein B, 2001, 'Ambulance calls to suspected overdoses: NSW patterns July 1997 to June 1999', Australian and New Zealand Journal of Public Health, pp. 447 - 450

Dillon PG; Degenhardt LJ, 2001, 'Ketamine and GHB: New trends in club drug use?', Journal of Substance Use, pp. 11 - 15

Degenhardt LJ; Hall WD, 2001, 'The association between psychosis and problematical drug use among Australian adults: Findings from the National Survey of Mental Health and Well-Being', Psychological Medicine, pp. 659 - 668

Degenhardt LJ; Hall WD; Lynskey MT, 2001, 'The relationship between cannabis use and other substance use in the general population', Drug and Alcohol Dependence, pp. 319 - 327

Degenhardt LJ; Hall WD; Lynskey MT, 2001, 'The relationship between cannabis use, depression and anxiety among Australian adults: Findings from the National Survey of Mental Health and Well-Being', Social Psychiatry and Psychiatric Epidemiology, pp. 219 - 227

Degenhardt LJ; Conigrave KM; Wutzke SE; Saunders JB, 2001, 'The validity of an Australian modification of the AUDIT questionnaire', Drug and Alcohol Review, 20, pp. 143 - 154

DEGENHARDT LJ; CONIGRAVE KM; WUTZKE SE; SAUNDERS JB, 2001, 'The validity of an Australian modification of the AUDIT questionnaire', Drug and Alcohol Review, 20, pp. 143 - 154, http://dx.doi.org/10.1080/09595230124592

Tabakoff B; Helander A; Conigrave KM; Martinez L; Hoffman PL; Whitfield J; Degenhardt LJ; Saunders J; Baron A; Glanz J, 2001, 'WHO/ISBRA study on state and trait markers in alcoholism', Alcoholism : Clinical and Experimental Research, pp. 99 - 103

Lynskey M; Degenhardt L; Hall W, 2000, 'Cohort trends in youth suicide in Australia 1964-1997', Australian and New Zealand Journal of Psychiatry, 34, pp. 408 - 412, http://dx.doi.org/10.1046/j.1440-1614.2000.00740.x

Lynskey M; Degenhardt L; Hall W, 2000, 'Cohort trends in youth suicide in Australia 1964-1997', Australian and New Zealand Journal of Psychiatry, 34, pp. 408 - 412, http://dx.doi.org/10.1046/j.1440-1614.2000.00740.x

Teesson M; Hall WD; Lynskey MT; Degenhardt LJ, 2000, 'Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and wellbeing', Australian and New Zealand Journal of Psychiatry, pp. 206 - 213

Hall WD; Degenhardt LJ, 2000, 'Cannabis use and psychosis: A review of clinical and epidemiological evidence', Australian and New Zealand Journal of Psychiatry, pp. 26 - 34

Degenhardt LJ, 2000, 'Interventions for people with alcohol use disorders and an intellectual disability: A review of the literature', Journal of Intellectual and Developmental Disability, pp. 135 - 146

Hall WD; Lynskey MT; Degenhardt LJ, 2000, 'Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995', Drug and Alcohol Dependence, pp. 247 - 254

Hall WD; Degenhardt LJ; Lynskey MT, 1999, 'Opioid overdose mortality in Australia, 1964-1997: Birth-cohort trends', Medical Journal of Australia, 171, pp. 34 - 37, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123495.x

Hall WD; Degenhardt LJ; Lynskey MT, 1999, 'Opioid overdose mortality in Australia, 1964-1997', Medical Journal of Australia, 171, pp. 34 - 37

Hall WD; Teesson M; Lynskey MT; Degenhardt LJ, 1999, 'The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being', Addiction, pp. 1541 - 1550

Hall WD; Degenhardt LJ, 1998, 'The decline in alcohol disorders with age: Causes and implications', Australian Journal on Ageing, 17, pp. 158 - 159

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International journal of population data science, 7

Bharat CI, 'The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Well-Being',

Conference Papers

Hopkins R; Bharat C; Buizen L; Close J; Ivers R; Draper B; Pearson S-A; Degenhardt L; Gisev N, 2024, '181 Age-related risk of serious fall events associated with opioid analgesic use', in Abstracts, BMJ Publishing Group Ltd, pp. A35.1 - A35, presented at 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) abstracts, http://dx.doi.org/10.1136/injuryprev-2024-safety.83

Slade T; Clare P; Yuen WS; Henderson A; Bruno R; Degenhardt L; Horwood J; Hutchinson D; Kypri K; McBride N; McCambridge J; Najman J; Wadolowski M; Mattick RP; Peacock A, 2023, 'Family and peer-related mediators of the relationship between parental supply of alcohol and subsequent alcohol-related harms among Australian adolescents', in ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, WILEY, WA, Bellevue, pp. 114 - 115, presented at 46th Annual Scientific Meeting of the Research-Society-on-Alcohol (RSA), WA, Bellevue, 24 June 2023 - 28 June 2023

Bharat C; Webb P; Wilkinson Z; McKetin R; Grebely J; Farrell M; Holland A; Hickman M; Tran LT; Clark B; Peacock A; Darke S; Li J-H; Degenhardt L, 2023, 'Agreement between self-reported illicit drug use and biological samples: A systematic review and meta-analysis', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S41 - S42

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L, 2023, 'Association of opioid analgesics, benzodiazepines, gabapentinoids and opioid agonist treatment with mortality among individuals with opioid dependence', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S40 - S41

Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M, 2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S65 - S66

Webb P; Ireland J; Colledge-Frisby S; Ottaviano S; Grebely J; Wheeler A; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L, 2023, 'Global patterns of drug use among people who inject drugs', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S183 - S184

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, 'National trends in the Australian opioid agonist treatment program, 2013 to 2022', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S40 - S40

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop AJ; Dore GJ; McDonough M; Montebello ME; Weiss R; Rodgers C; Cook J; Degenhardt L, 2023, 'Ninety-six week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a singlearm trial', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S72 - S73

Santo T; Campbell G; Gisev N; Martino-Burke D; Colledge-Frisby S; Clark B; Tran LT; Degenhardt L, 2023, 'Prevalence of substance use disorders among individuals with opioid use disorder: A systematic review and meta-analysis', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S162 - S162

Gisev N; Buizen L; Bharat C; Larney S; Currow D; Blyth FM; Dobbins T; Pearson S-A; Degenhardt L, 2023, 'The risk of fatal opioid overdose associated with the concurrent use of opioid analgesics and psychotropic medicines: A retrospective population-based cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 589 - 590

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'How can a new formulation reduce stigma linked to opiate agonist treatment?: Place, time and things in the experience of extended-release buprenorphine depot', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S137 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page